Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease
暂无分享,去创建一个
S. Miyamoto | Takeshi Kimura | H. Izawa | M. Nakatochi | M. Yokota | Ken Yamamoto | K. Ono | A. Koizumi | Kouji H. Harada | T. Matsubara | S. Ichihara | Y. Mineharu | Takeshi Funaki | Katsunobu Takenaka | Hatasu Kobayashi | Y. Takagi | Lan-ying Zhao | Risako Kabata | Takaaki Morimoto | Yang Cao | T. Funaki | Lanying Zhao
[1] T. Ogihara,et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2 , 2009, Hypertension Research.
[2] T. Funahashi,et al. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. , 2007, Journal of atherosclerosis and thrombosis.
[3] Gao T. Wang,et al. RNF213 Rare Variants in an Ethnically Diverse Population With Moyamoya Disease , 2014, Stroke.
[4] A. Folsom,et al. Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. , 2000, International journal of epidemiology.
[5] H. Izawa,et al. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population , 2010, Diabetologia.
[6] Eloi Marijon,et al. State-of-the-art Paper Prevalences, Patterns, and the Potential of Early Disease Detection , 2022 .
[7] Y. Kuroiwa,et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease , 2012, Neurology.
[8] K. Nakao,et al. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. , 2013, Biochemical and biophysical research communications.
[9] Sung-il Cho,et al. Time Trend and Age-Period-Cohort Effects on Acute Myocardial Infarction Mortality in Korean Adults from 1988 to 2007 , 2011, Journal of Korean medical science.
[10] C. Antoniades,et al. Wnt signaling in cardiovascular physiology , 2012, Trends in Endocrinology & Metabolism.
[11] Hiroyuki Asano,et al. Relation of a common variant of the adiponectin gene to serum adiponectin concentration and metabolic traits in an aged Japanese population , 2011, European Journal of Human Genetics.
[12] A Takaku,et al. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.
[13] Kouichi Ozaki,et al. Molecular genetics of coronary artery disease , 2015, Journal of Human Genetics.
[14] A. Hata,et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene , 2011, Journal of Human Genetics.
[15] D Kromhout,et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. , 1995, JAMA.
[16] A. Koizumi,et al. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population , 2016, Environmental Health and Preventive Medicine.
[17] J. Hoseki,et al. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state , 2014, Scientific Reports.
[18] M. Guan,et al. Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population , 2012, PloS one.
[19] Y. Zhang,et al. Body Mass Index, High-Sensitivity C-Reactive Protein and Mortality in Chinese with Coronary Artery Disease , 2015, PloS one.
[20] K. Nozaki,et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[21] D. Taura,et al. Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo , 2015, Journal of the American Heart Association.
[22] O. Delaneau,et al. Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .
[23] K. Tatara,et al. Heart disease deaths in a Japanese urban area evaluated by clinical and police records. , 1994, Circulation.
[24] Robert K. Yu,et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. , 2009, American journal of human genetics.
[25] S. Nanayakkara,et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure , 2013, Environmental Health and Preventive Medicine.
[26] Wenhua Zhao,et al. Emergence of chronic non-communicable diseases in China , 2008, The Lancet.
[27] W. Sheu,et al. A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. , 2014, Human molecular genetics.
[28] A. Fujiyama,et al. Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development , 2011, PloS one.
[29] K. Yamagishi,et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: the Akita-Osaka study. , 2008, Journal of the American College of Cardiology.
[30] K. Houkin,et al. Review of past and present research on experimental models of moyamoya disease , 2015 .
[31] H. Izawa,et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002, The New England journal of medicine.
[32] K. Houkin,et al. Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells , 2016, PloS one.
[33] A. Koizumi,et al. A new horizon of moyamoya disease and associated health risks explored through RNF213 , 2015, Environmental Health and Preventive Medicine.
[34] Jing He,et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation , 2015, Nature Genetics.
[35] Jingwen,et al. A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. , 2014, Human molecular genetics.
[36] E. Ikeda. Systemic Vascular Changes in Spontaneous Occlusion of the Circle of Willis , 1991, Stroke.
[37] David M. Herrington,et al. Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction , 2014, Nature.
[38] E. Sparks,et al. Genomics and cardiovascular disease. , 2005, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.
[39] A. Mukasa,et al. Genetic Variant RNF213 c.14576G>A in Various Phenotypes of Intracranial Major Artery Stenosis/Occlusion , 2013, Stroke.
[40] 峰晴 陽平. Autosomal dominant moyamoya disease maps to chromosome 17q25.3 , 2008 .
[41] K. Tanaka,et al. Histopathology of the brain vascular network in moyamoya disease. , 1983, Stroke.
[42] C. Ki,et al. Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals , 2015, BMC Medical Genetics.
[43] K. Nozaki,et al. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. , 2007, Neurologia medico-chirurgica.
[44] Seung-Chyul Hong,et al. Coronary Heart Disease in Moyamoya Disease: Are They Concomitant or Coincidence? , 2015, Journal of Korean medical science.
[45] Hiroyuki Honda,et al. The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study. , 2011, Diabetes research and clinical practice.
[46] K. Kawakami,et al. Neuromuscular regulation in zebrafish by a large AAA+ ATPase/ubiquitin ligase, mysterin/RNF213 , 2015, Scientific Reports.
[47] Kohjiro Ueki,et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.
[48] T. Ogihara,et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) , 2009, Hypertension Research.
[49] H. Augustin,et al. Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca(2+)/NFAT Signaling. , 2016, Developmental cell.
[50] K. Kosaki,et al. Homozygosity for moyamoya disease risk allele leads to moyamoya disease with extracranial systemic and pulmonary vasculopathy , 2016, American journal of medical genetics. Part A.
[51] Y. Hosoda,et al. Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular Moyamoya disease) , 1997, Clinical Neurology and Neurosurgery.
[52] B. Gersh. Trends in the Incidence of Coronary Heart Disease and Stroke and Their Risk Factors in Japan, 1964 to 2003: The Akita-Osaka Study , 2009 .
[53] Exome sequencing identifies rare LDLR and APOA 5 alleles conferring risk for myocardial infarction , 2016 .
[54] A. Koizumi,et al. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. , 2012, Neurologia medico-chirurgica.
[55] K. Nakao,et al. The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality. , 2013, Biochemical and biophysical research communications.
[56] K. Maeda,et al. Trends in sudden cardiac death and its risk factors in Japan from 1981 to 2005: the Circulatory Risk in Communities Study (CIRCS) , 2012, BMJ Open.
[57] K. Sunagawa,et al. Identification of a Glutamic Acid Repeat Polymorphism of ALMS1 as a Novel Genetic Risk Marker for Early-Onset Myocardial Infarction by Genome-Wide Linkage Analysis , 2013, Circulation. Cardiovascular genetics.